Opportunity ID: 253062
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-PS-14-004 |
Funding Opportunity Title: | Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 93.270 — Adult Viral Hepatitis Prevention and Control |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Mar 26, 2014 |
Last Updated Date: | Apr 10, 2014 |
Original Closing Date for Applications: | Apr 30, 2014 |
Current Closing Date for Applications: | Apr 30, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $1,800,000 |
Award Ceiling: | $300,000 |
Award Floor: | $250,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Eligible Organizations
Higher Education Institutions: The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Nonprofits Other Than Institutions of Higher Education For-Profit Organizations Governments 2.Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose and overarching goal of this cooperative agreement is to address the high prevalence of viral hepatitis C infection by developing and implementing an integrated approach for detection, prevention, care and treatment of Hepatitis C infection among young (18-30 year old), non-urban people who inject drugs (PWID). Awardees will develop and implement a comprehensive strategy to enroll young non-urban PWID, collect epidemiological information, test for HCV infection and provide linkage to primary care services and prevention-based education. In addition to providing hepatitis C virus (HCV) testing, awardees will provide testing for the presence of co-infections with hepatitis B virus (HBV) and HIV. Rates of HCV infection or re-infection will be evaluated through follow-up assessment. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Amendment II, dated April 10, 2014 is being made to the following, in green font on the corresponding pages:
Pages 48 to 52: The Summary of the Conference Call with Potential Applicants for Funding Opportunity Announcement (FOA): PS14-004 ¿Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs (PWID)¿ and the questions and answers from the call have been added. |
Apr 10, 2014 | |
Amendment II, dated April 10, 2014 is being made to the following, in green font on the corresponding pages:
Pages 48 to 52: The Summary of the Conference Call with Potential Applicants for Funding Opportunity Announcement (FOA): PS14-004 “Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs (PWID)” and the questions and answers from the call have been added. |
Apr 10, 2014 | |
Apr 10, 2014 |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-PS-14-004 |
Funding Opportunity Title: | Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 93.270 — Adult Viral Hepatitis Prevention and Control |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Mar 26, 2014 |
Last Updated Date: | Apr 10, 2014 |
Original Closing Date for Applications: | Apr 30, 2014 |
Current Closing Date for Applications: | Apr 30, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $1,800,000 |
Award Ceiling: | $300,000 |
Award Floor: | $250,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Eligible Organizations
Higher Education Institutions: The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Nonprofits Other Than Institutions of Higher Education For-Profit Organizations Governments 2.Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose and overarching goal of this cooperative agreement is to address the high prevalence of viral hepatitis C infection by developing and implementing an integrated approach for detection, prevention, care and treatment of Hepatitis C infection among young (18-30 year old), non-urban people who inject drugs (PWID). Awardees will develop and implement a comprehensive strategy to enroll young non-urban PWID, collect epidemiological information, test for HCV infection and provide linkage to primary care services and prevention-based education. In addition to providing hepatitis C virus (HCV) testing, awardees will provide testing for the presence of co-infections with hepatitis B virus (HBV) and HIV. Rates of HCV infection or re-infection will be evaluated through follow-up assessment. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-PS-14-004 |
Funding Opportunity Title: | Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 93.270 — Adult Viral Hepatitis Prevention and Control |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Apr 10, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 30, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $1,800,000 |
Award Ceiling: | $300,000 |
Award Floor: | $250,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Eligible Organizations
Higher Education Institutions: The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Nonprofits Other Than Institutions of Higher Education For-Profit Organizations Governments 2.Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose and overarching goal of this cooperative agreement is to address the high prevalence of viral hepatitis C infection by developing and implementing an integrated approach for detection, prevention, care and treatment of Hepatitis C infection among young (18-30 year old), non-urban people who inject drugs (PWID). Awardees will develop and implement a comprehensive strategy to enroll young non-urban PWID, collect epidemiological information, test for HCV infection and provide linkage to primary care services and prevention-based education. In addition to providing hepatitis C virus (HCV) testing, awardees will provide testing for the presence of co-infections with hepatitis B virus (HBV) and HIV. Rates of HCV infection or re-infection will be evaluated through follow-up assessment. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-PS-14-004 |
Funding Opportunity Title: | Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 93.270 — Adult Viral Hepatitis Prevention and Control |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 10, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Apr 30, 2014 |
Archive Date: | May 30, 2014 |
Estimated Total Program Funding: | $1,800,000 |
Award Ceiling: | $300,000 |
Award Floor: | $250,000 |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Eligible Organizations
Higher Education Institutions: The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Nonprofits Other Than Institutions of Higher Education For-Profit Organizations Governments 2.Foreign Organizations Foreign components of U.S. Organizations are not eligible to apply. |
Additional Information
Agency Name: | Centers for Disease Control and Prevention – ERA |
Description: | The purpose and overarching goal of this cooperative agreement is to address the high prevalence of viral hepatitis C infection by developing and implementing an integrated approach for detection, prevention, care and treatment of Hepatitis C infection among young (18-30 year old), non-urban people who inject drugs (PWID). Awardees will develop and implement a comprehensive strategy to enroll young non-urban PWID, collect epidemiological information, test for HCV infection and provide linkage to primary care services and prevention-based education. In addition to providing hepatitis C virus (HCV) testing, awardees will provide testing for the presence of co-infections with hepatitis B virus (HBV) and HIV. Rates of HCV infection or re-infection will be evaluated through follow-up assessment. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
Related Documents
Packages
Agency Contact Information: | Centers for Disease Control and Prevention (CDC) Procurement and Grants Office (PGO) Phone: 770-488-2700 Email: pgotim@cdc.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.270 | NCHHSTP-R | Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis-TIPS) among Non-urban Young Persons Who Inject Drugs | PKG00194435 | Mar 26, 2014 | Apr 30, 2014 | View |